Chemoinformaics analysis of Hederagenin-3-O-Alpha-Lrhemnopyranosyl...Pyranoside
| Molecular Weight | 634.851 | nRot | 5 |
| Heavy Atom Molecular Weight | 576.387 | nRig | 33 |
| Exact Molecular Weight | 634.408 | nRing | 6 |
| Solubility: LogS | -3.412 | nHRing | 1 |
| Solubility: LogP | 3.47 | No. of Aliphatic Rings | 6 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 103 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 106.012 |
| nHD | 6 | BPOL | 62.526 |
| QED | 0.194 |
| Synth | 5.298 |
| Natural Product Likeliness | 3.12 |
| NR-PPAR-gamma | 0.817 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.614 |
| CACO-2 | -5.479 |
| MDCK | 0.0000122 |
| BBB | 0.078 |
| PPB | 0.951501 |
| VDSS | 0.718 |
| FU | 0.0472678 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.413 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.849 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.134 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.131 |
| CYP3a4-inh | 0.063 |
| CYP3a4-sub | 0.078 |
| CL | 1.184 |
| T12 | 0.052 |
| hERG | 0.002 |
| Ames | 0.099 |
| ROA | 0.102 |
| SkinSen | 0.004 |
| Carcinogencity | 0.041 |
| EI | 0.005 |
| Respiratory | 0.866 |
| NR-Aromatase | 0.86 |
| Antiviral | Yes |
| Prediction | 0.797585 |